Atorvastatin Calcium Tablet
Product Images NDC 71335-2582

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-2582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Chemical structure of atorvastatin calcium. The diagram shows the molecular structure representing two atorvastatin calcium molecules complexed with calcium ions and water molecules.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

A line graph comparing the cumulative incidence (%) of an outcome over 3.5 years between Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing lower incidence than the dashed line for placebo. Data includes hazard ratio (HR=0.64) and p-value (p=0.0005).*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

A line graph depicting cumulative hazard percentage over five years comparing Atorvastatin and placebo. The x-axis represents time to first primary endpoint through four years of follow-up (in years), and the y-axis shows cumulative hazard percentage. Two lines represent placebo (dashed) and Atorvastatin (solid), with Atorvastatin demonstrating a lower hazard rate over time. The graph includes a hazard ratio (HR 0.63) with confidence interval and p-value.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

A line graph comparing time to first major cardiovascular event over five years between subjects taking 10 mg and 80 mg doses of atorvastatin. The y-axis shows the percentage of subjects experiencing the event, with two lines representing atorvastatin 10 mg (dotted) and 80 mg (solid). A hazard ratio of 0.78 with confidence interval (0.69-0.89) and P=0.0002 is noted on the graph.*

FDA Label Image

Label (Lbl713352582)

Atorvastatin Calcium Tablets USP 80 mg oral tablets packaging label, NDC 71335-2582-1. The label indicates 30 tablets per container. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Graviti Pharmaceuticals Pvt. Ltd. Storage instructions and QR codes for package insert are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.